StockData
Lucid Diagnostics Inc. logo

Lucid Diagnostics Inc. (LUCD) stock

LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3034% above fair value
$0.40+0.00 (+0.30%)

Close on Nov 17, 2026Market cap $81.09MP/E –Yield –

Earnings

Lucid Diagnostics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 25, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$1.20M
0.0% on a year earlier
non-GAAP adjusted loss per common share, Q3 FY2026
-$0.06
-$0.10 a year earlier
Latest guidance
Issued
Mar 14, 2023 · 1 item

Quarterly results

Revenue and earnings per share from each of Lucid Diagnostics's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Mar 25, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 12, 2026before the open$1.20M0.0%-$0.03-$0.06Release
Q2 FY2026ended Jun 30, 2026Aug 13, 2026before the open$1.50M+25.0%-$0.08-$0.06Release
Q1 FY2026ended Mar 31, 2026May 14, 2026before the open$1.26M+57.0%-$0.17-$0.07Release
Q4 FY2025ended Dec 31, 2025Mar 26, 2026before the open$1.50M+25.0%-$0.12-$0.10Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025before the open$1.20M0.0%-$0.10-$0.10Release
Q2 FY2025ended Jun 30, 2025Aug 13, 2025before the open$1.20M+20.0%-$0.08-$0.10Release
Q1 FY2025ended Mar 31, 2025May 14, 2025before the open$800.00K-20.0%-$0.52-$0.16Release
Q4 FY2024ended Dec 31, 2024Mar 25, 2025before the open$1.20M–-$0.20-$0.19Release
Q3 FY2024ended Sep 30, 2024Nov 13, 2024before the open$1.20M+53.3%––Release
Q2 FY2024ended Jun 30, 2024Aug 12, 2024before the open$1.00M–-$0.23-$0.20Release
Q1 FY2024ended Mar 31, 2024May 14, 2024before the open$1.00M–-$0.40-$0.21Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

No open guidance: every period Lucid Diagnostics guided for has been reported

Guidance history

Every forecast Lucid Diagnostics put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Mar 14, 2023commercial EsoGuard testsQ1 FY20231600New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Lucid Diagnostics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Results
  4. Results
  5. Update
  6. Update
  7. Results
  8. Results
  9. Update
  10. Update
  11. Update
  12. Update
  13. Results
  14. Results
  15. Update

See a number that looks wrong?